Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Surgery Partners (SGRY) Enterprise Value (2016 - 2025)

Surgery Partners' Enterprise Value history spans 12 years, with the latest figure at $1.2 billion for Q4 2025.

  • For Q4 2025, Enterprise Value rose 3.63% year-over-year to $1.2 billion; the TTM value through Dec 2025 reached $1.2 billion, up 3.63%, while the annual FY2025 figure was $1.2 billion, 3.63% up from the prior year.
  • Enterprise Value for Q4 2025 was $1.2 billion at Surgery Partners, down from $1.2 billion in the prior quarter.
  • Across five years, Enterprise Value topped out at $1.2 billion in Q3 2025 and bottomed at -$233.7 million in Q1 2021.
  • The 5-year median for Enterprise Value is $135.0 million (2023), against an average of $289.9 million.
  • The largest annual shift saw Enterprise Value crashed 1210.34% in 2021 before it skyrocketed 1020.0% in 2022.
  • A 5-year view of Enterprise Value shows it stood at -$59.7 million in 2021, then soared by 198.99% to $59.1 million in 2022, then skyrocketed by 122.5% to $131.5 million in 2023, then soared by 764.79% to $1.1 billion in 2024, then increased by 3.63% to $1.2 billion in 2025.
  • Per Business Quant, the three most recent readings for SGRY's Enterprise Value are $1.2 billion (Q4 2025), $1.2 billion (Q3 2025), and $172.3 million (Q2 2025).